CONSULTING AGREEMENTConsulting Agreement • August 6th, 2015 • Cerulean Pharma Inc. • Pharmaceutical preparations • Massachusetts
This Consulting Agreement (the “Agreement”) is made effective as of May 27, 2015 (the “Effective Date”), by and between Cerulean Pharma Inc., a Delaware corporation, with its principal place of business being 840 Memorial Drive, 5th Floor, Cambridge, MA 02139 (the “Company”) and Danforth Advisors, LLC, a Massachusetts limited liability corporation, with its principal place of business being 91 Middle Road, Southborough, MA 01772 (“Danforth”). The Company and Danforth are herein sometimes referred to individually as a “Party” and collectively as the “Parties.”
LEASE OF PREMISES AT 35 GATEHOUSE DRIVE, WALTHAM, MASSACHUSETTS FROM ASTRAZENECA PHARMACEUTICALS LIMITED PARTNERSHIP TO CERULEAN PHARMA INC.Lease • August 6th, 2015 • Cerulean Pharma Inc. • Pharmaceutical preparations • Delaware
The following is a summary of certain basic terms of this Lease which is intended for the convenience and reference of the parties. Capitalized terms used, but not defined, in this Summary of Basic Terms, have their defined meanings in this Lease. In addition, some of the following items or terms are incorporated into this Lease by reference to the item or term or to this “Summary of Basic Terms”.
TRANSITION AND SEPARATION AGREEMENTTransition and Separation Agreement • August 6th, 2015 • Cerulean Pharma Inc. • Pharmaceutical preparations • Massachusetts
This Transition and Separation Agreement (the “Agreement”) is made by and between Cerulean Pharma Inc. (the “Company”) and Karen Roberts (“Ms. Roberts”) (collectively, the “Parties”).
